
An antibody found in the blood of sharks could help tackle breast cancer, say researchers.
It is thought that the unique IgNAR antibodies could be used to prevent the growth of cancer cells and research into them could lead to the development of new drugs to fight one of the most common form of the disease, News.com.au reported.
Advertisement
Biologists from the University of Aberdeen have been awarded 345,660 Australian dollars by Scottish cancer research charity the Association for International Cancer Research (AICR) to carry out a three-year study.
Their work will focus on two molecules, HER2 and HER3, found on the surface of cancer cells which, when they pair-up, are responsible for signalling cancer cells to grow and divide.
Potentially, IgNAR antibodies could be used to stop these molecules from working and sending the signal.
Dr Helen Dooley who is from the university's School of Biological Sciences and will lead the study sais that IgNAR antibodies are interesting because they bind to targets, such as viruses or parasites, in a very different way to the antibodies found in humans.
Source: ANI
Advertisement
Potentially, IgNAR antibodies could be used to stop these molecules from working and sending the signal.
Dr Helen Dooley who is from the university's School of Biological Sciences and will lead the study sais that IgNAR antibodies are interesting because they bind to targets, such as viruses or parasites, in a very different way to the antibodies found in humans.
Source: ANI
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.

HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.